secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-08-01T23:59:59+00:00
Accession:  0001213900-23-061514
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition stockholders approve merger with Estrella Biopharma; 650K shares redeemed
--------------------------------------------------------------------------------

- Stockholders voted 1,884,258 for vs 631 against to adopt Merger Agreement with Estrella Biopharma.
- All six charter amendment proposals passed, including name change to Estrella Immunopharma, Inc.
- Directors appointed: Cheng Liu, Marsha Roberts, Fan Wu, Janelle Wu, Pei Xu.
- Estrella Immunopharma 2023 Omnibus Incentive Plan approved, contingent on closing.
- 650,580 shares of common stock were redeemed in connection with the vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023061514/0001213900-23-061514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023061514/ea182664-8k425_tradeup.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-061514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer